Loading interface...

Maczone Plus 750 Injection

Manufactured byMACLEODS PHARMACEUTICALS PVT.LTD
ContainsCeftriaxone (500 mg) + Sulbactam (250 mg)
Description
Maczone Plus 750 Injection is a combination medicine used for the treatment of infections of the lower respiratory tract, ears, skin and skin structure, etc. caused by susceptible bacteria. This medicine is not recommended for use in patients less than 28 days of age (neonates).

Side effects

Major & minor side effects for Maczone Plus 750 Injection

  • Diarrhea
  • Nausea and Vomiting
  • Itching
  • Fatigue
  • Chills
  • Edema
  • Black or tarry stools
  • Chest pain
  • Fever
  • Difficult or painful urination
  • Sore throat
  • Abdominal pain
  • Dizziness
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Acid or sour stomach
  • Change in taste
  • Excessive air or gas in stomach

Uses of Maczone Plus 750 Injection

What is it prescribed for?

  • Bacterial infections
  • Bacterial Meningitis
  • Skin and Skin Structure Infection
  • Acute bacterial otitis media
  • Lower Respiratory Tract Infection
  • Surgical prophylaxis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine occurs rapidly after an intravenous or intramuscular administration.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to ceftriaxone, sulbactam, any other beta-lactam antibiotics, or any other inactive ingredients present along with these medicines.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Renal impairment

This medicine should be used with caution in patients with a known history of renal function impairment due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Prothrombin time

Alterations in prothrombin time (a test used to check for bleeding problems) have been reported in patients receiving this medicine. Regular monitoring of prothrombin time may be necessary for some patients. Replacement with a suitable alternative may be required in some cases based on the clinical condition.

Drug-resistance

Usage of this medicine without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of development of bacteria that are drug resistant.

Clostridium difficile-associated Diarrhea

Antibiotic therapy will cause an imbalance in the normal microbial flora of the large intestine, which may promote the growth of a bacteria called Clostridium difficile and you may experience severe diarrhea as a result. Report any such incidence to the doctor on priority. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Use in neonates

This medicine is not recommended for use in patients less than 28 days of age since the safety and efficacy of use are not clinically established.

Hepatic impairment

This medicine should be used with caution in patients with liver function impairment due to the increased risk of worsening of the patient's condition. Regular monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Electrolyte imbalance

This medicine should be used with caution in patients with a known history of electrolyte imbalance since it may worsen the patient's condition. Report any unusual symptoms to the doctor immediately. Close monitoring of electrolyte levels, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Missed Dose

Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Ethinyl Estradiol

Cholera Vaccine

Amikacin

Probenecid

Cyclosporine

Disease interactions

Renal impairment

This medicine should be used with caution in patients with a known history of renal diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Gastrointestinal Diseases

This medicine should be used with caution since it may cause diarrhea, abdominal pain, and blood in stools in some cases. This risk is especially higher in patients with a history of gastrointestinal diseases, particularly colitis. Report any such symptoms to the doctor immediately. Replacement with a suitable alternative may be required in some cases based on the clinical condition.

Seizure disorders

This medicine should be used with caution in patients with a history of seizure disorder or a family history of seizures since it may worsen the patient's condition. Report any unusual symptoms to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine should be administered by a qualified healthcare professional in the clinical or hospital setting. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines as well as your medical conditions before receiving this medicine. Report any undesirable side effects to the doctor promptly.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
Ceftriaxone works by interfering with certain processes that help the bacteria to grow and increase in number. Sulbactam inhibits some chemicals produced by the bacteria and makes the bacteria more sensitive to ceftriaxone activity. Their combination thus becomes effective against an extended range of bacteria.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Third generation cephalosporins, Beta-lactamase inhibitors

Schedule

Schedule H

Cefossin [Internet]. Biotavia.com. 2018 [cited 29 March 2018]. Available from:

http://www.biotavia.com/pharm/products/domestic/cefossin.html

Blue Cross Laboratories Pvt Ltd. - World Class Quality Medicines At Affordable Prices [Internet]. Bluecrosslabs.com. 2018 [cited 29 March 2018]. Available from:

http://www.bluecrosslabs.com/bc-18.html

[Internet]. CiplaMed. 2018 [cited 19 March 2018]. Available from:

https://ciplamed.com/content/sulbacip-iv-injection
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Jul 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.